Oric Pharmaceuticals
ORIC
ORIC
83 hedge funds and large institutions have $353M invested in Oric Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 70 → 83 (+13)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
68% less call options, than puts
Call options by funds: $336K | Put options by funds: $1.03M
Holders
83
Holding in Top 10
7
Calls
$336K
Puts
$1.03M
Top Buyers
| 1 | +$33.3M | |
| 2 | +$16.6M | |
| 3 | +$16.6M | |
| 4 |
BlackRock
New York
|
+$14.6M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$9.44M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$8.63M | |
| 3 | -$2.13M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.77M |
| 5 |
O
OrbiMed
New York
|
-$1.6M |